Contact Kinex Pharmaceuticals

About Us Team Pipeline News Contact Us Careers Home
Kinex Named to Science Coalition List

Kinex to Present at the 101st Annual AACR Meeting

Kinex Technology Highlighted at American Chemical Society Symposium

Charles E. Lannon Appointed as Vice-Chairman of the Board at Kinex Pharmaceuticals

Kinex Pharmaceuticals Initiates a Phase 2 Clinical Trial of KX2-391 in Patients with Prostate Cancer

More headlines ...

Kinex News


Back to headlines

March 7, 2008
Kinex Co-Founder Appointed to NYBA Board

Lyn M. Dyster Ph.D., co-founder and vice president of research operations at Kinex Pharmaceuticals has been appointed to a four-year term on the Board of Directors of the New York State Biotechnology Association (NYBA).

The New York Biotechnology Association is a not-for-profit trade association of more than 250 companies dedicated to the development and growth of New York State based biotechnology related industries and institutions. Its mission is to strengthen the competitiveness of New York State as a premier global location for biotechnology/biomedical research, education and industry.